MR1 antigen presentation to MAIT cells and other MR1-restricted T cells.

Pishesha, N., Harmand, T. J. & Ploegh, H. L. A guide to antigen processing and presentation. Nat. Rev. Immunol. 22, 751–764 (2022).

pubmed: 35418563 doi: 10.1038/s41577-022-00707-2

Li, D. & Wu, M. Pattern recognition receptors in health and diseases. Signal Transduct. Target. Ther. 6, 291 (2021).

pubmed: 34344870 pmcid: 8333067 doi: 10.1038/s41392-021-00687-0

Barral, D. C. & Brenner, M. B. CD1 antigen presentation: how it works. Nat. Rev. Immunol. 7, 929–941 (2007).

pubmed: 18037897 doi: 10.1038/nri2191

Rossjohn, J. et al. T cell antigen receptor recognition of antigen-presenting molecules. Annu. Rev. Immunol. 33, 169–200 (2015).

pubmed: 25493333 doi: 10.1146/annurev-immunol-032414-112334

Le Bourhis, L. et al. Antimicrobial activity of mucosal-associated invariant T cells. Nat. Immunol. 11, 701–708 (2010).

pubmed: 20581831 doi: 10.1038/ni.1890

Gold, M. C. et al. Human mucosal associated invariant T cells detect bacterially infected cells. PLoS Biol. 8, e1000407 (2010).

pubmed: 20613858 pmcid: 2893946 doi: 10.1371/journal.pbio.1000407

McWilliam, H. E. et al. The intracellular pathway for the presentation of vitamin B-related antigens by the antigen-presenting molecule MR1. Nat. Immunol. 17, 531–537 (2016). This study outlines the trafficking pathway followed by MR1 from its synthesis in the ER to its degradation in endosomes and the role of VitBAg in regulation of MR1 expression.

pubmed: 27043408 doi: 10.1038/ni.3416

Jeffery, H. C. et al. Biliary epithelium and liver B cells exposed to bacteria activate intrahepatic MAIT cells through MR1. J. Hepatol. 64, 1118–1127 (2016).

pubmed: 26743076 pmcid: 4822535 doi: 10.1016/j.jhep.2015.12.017

Kjer-Nielsen, L. et al. MR1 presents microbial vitamin B metabolites to MAIT cells. Nature 491, 717–723 (2012). This study reveals that MR1 binds and presents VitBAgs to MAIT cells.

pubmed: 23051753 doi: 10.1038/nature11605

Corbett, A. J. et al. T-cell activation by transitory neo-antigens derived from distinct microbial pathways. Nature 509, 361–365 (2014). This study identifies the most potent MR1 antigens, the 5-A-RU-derived pyrimidines such as 5-OP-RU.

pubmed: 24695216 doi: 10.1038/nature13160

García-Angulo, V. A. Overlapping riboflavin supply pathways in bacteria. Crit. Rev. Microbiol. 43, 196–209 (2017).

pubmed: 27822970 doi: 10.1080/1040841X.2016.1192578

Tilloy, F. et al. An invariant T cell receptor α chain defines a novel TAP-independent major histocompatibility complex class Ib-restricted α/β T cell subpopulation in mammals. J. Exp. Med. 189, 1907–1921 (1999).

pubmed: 10377186 pmcid: 2192962 doi: 10.1084/jem.189.12.1907

Treiner, E. et al. Selection of evolutionarily conserved mucosal-associated invariant T cells by MR1. Nature 422, 164–169 (2003). This study outlines the discovery that MAIT cells are restricted by MR1.

pubmed: 12634786 doi: 10.1038/nature01433

Porcelli, S., Yockey, C. E., Brenner, M. B. & Balk, S. P. Analysis of T cell antigen receptor (TCR) expression by human peripheral blood CD4

pubmed: 8391057 doi: 10.1084/jem.178.1.1

Kjer-Nielsen, L. et al. An overview on the identification of MAIT cell antigens. Immunol. Cell Biol. 96, 573–587 (2018).

pubmed: 29656544 doi: 10.1111/imcb.12057

Gherardin, N. A., McCluskey, J., Rossjohn, J. & Godfrey, D. I. The diverse family of MR1-restricted T cells. J. Immunol. 201, 2862–2871 (2018).

pubmed: 30397170 doi: 10.4049/jimmunol.1801091

Godfrey, D. I., Koay, H.-F., McCluskey, J. & Gherardin, N. A. The biology and functional importance of MAIT cells. Nat. Immunol. 20, 1110–1128 (2019).

pubmed: 31406380 doi: 10.1038/s41590-019-0444-8

Lantz, O. & Legoux, F. MAIT cells: an historical and evolutionary perspective. Immunol. Cell Biol. 96, 564–572 (2018).

pubmed: 29363173 doi: 10.1111/imcb.1034

Koay, H.-F. et al. Diverse MR1-restricted T cells in mice and humans. Nat. Commun. 10, 2243 (2019).

pubmed: 31113973 pmcid: 6529461 doi: 10.1038/s41467-019-10198-w

Martin, E. et al. Stepwise development of MAIT cells in mouse and human. PLoS Biol. 7, e54 (2009).

pubmed: 19278296 doi: 10.1371/journal.pbio.1000054

Koay, H. F. et al. A three-stage intrathymic development pathway for the mucosal-associated invariant T cell lineage. Nat. Immunol. 17, 1300–1311 (2016).

pubmed: 27668799 doi: 10.1038/ni.3565

Gold, M. C. et al. Human thymic MR1-restricted MAIT cells are innate pathogen-reactive effectors that adapt following thymic egress. Mucosal Immunol. 6, 35–44 (2013).

pubmed: 22692454 doi: 10.1038/mi.2012.45

Legoux, F. et al. Microbial metabolites control the thymic development of mucosal-associated invariant T cells. Science 366, 494–499 (2019). This study shows that MR1 expressed in the thymus presents antigen from peripheral tissues for MAIT cell development.

pubmed: 31467190 doi: 10.1126/science.aaw2719

Constantinides, M. G. et al. MAIT cells are imprinted by the microbiota in early life and promote tissue repair. Science 366, eaax6624 (2019).

pubmed: 31649166 pmcid: 7603427 doi: 10.1126/science.aax6624

Reantragoon, R. et al. Antigen-loaded MR1 tetramers define T cell receptor heterogeneity in mucosal-associated invariant T cells. J. Exp. Med. 210, 2305–2320 (2013).

pubmed: 24101382 pmcid: 3804952 doi: 10.1084/jem.20130958

Gherardin, N. A. et al. Human blood MAIT cell subsets defined using MR1 tetramers. Immunol. Cell Biol. 96, 507–525 (2018).

pubmed: 29437263 pmcid: 6446826 doi: 10.1111/imcb.12021

Meierovics, A., Yankelevich, W. J. & Cowley, S. C. MAIT cells are critical for optimal mucosal immune responses during in vivo pulmonary bacterial infection. Proc. Natl Acad. Sci. USA 110, E3119–E3128 (2013).

pubmed: 23898209 pmcid: 3746930 doi: 10.1073/pnas.1302799110

Le Bourhis, L. et al. MAIT cells detect and efficiently lyse bacterially-infected epithelial cells. PLoS Pathog. 9, e1003681 (2013).

pubmed: 24130485 pmcid: 3795036 doi: 10.1371/journal.ppat.1003681

Wang, H. et al. MAIT cells protect against pulmonary Legionella longbeachae infection. Nat. Commun. 9, 3350 (2018).

pubmed: 30135490 pmcid: 6105587 doi: 10.1038/s41467-018-05202-8

Leng, T. et al. TCR and inflammatory signals tune human MAIT cells to exert specific tissue repair and effector functions. Cell Rep. 28, 3077–3091.e5 (2019).

pubmed: 31533032 pmcid: 6899450 doi: 10.1016/j.celrep.2019.08.050

Du Halgouet, A. et al. Role of MR1-driven signals and amphiregulin on the recruitment and repair function of MAIT cells during skin wound healing. Immunity 56, 78–92.e6 (2023).

pubmed: 36630919 pmcid: 9839364 doi: 10.1016/j.immuni.2022.12.004

Smith, A. D. et al. Microbiota of MR1 deficient mice confer resistance against Clostridium difficile infection. PLoS ONE 14, e0223025 (2019).

pubmed: 31560732 pmcid: 6764671 doi: 10.1371/journal.pone.0223025

Varelias, A. et al. Recipient mucosal-associated invariant T cells control GVHD within the colon. J. Clin. Invest. 128, 1919–1936 (2018).

pubmed: 29629900 pmcid: 5919881 doi: 10.1172/JCI91646

Crowther, M. D. & Sewell, A. K. The burgeoning role of MR1-restricted T-cells in infection, cancer and autoimmune disease. Curr. Opin. Immunol. 69, 10–17 (2021).

pubmed: 33434741 doi: 10.1016/j.coi.2020.12.002

Shibata, K. et al. Symbiotic bacteria-dependent expansion of MR1-reactive T cells causes autoimmunity in the absence of Bcl11b. Nat. Commun. 13, 6948 (2022).

pubmed: 36376329 pmcid: 9663695 doi: 10.1038/s41467-022-34802-8

Gherardin, N. A. et al. Diversity of T cells restricted by the MHC class I-related molecule MR1 facilitates differential antigen recognition. Immunity 44, 32–45 (2016).

pubmed: 26795251 doi: 10.1016/j.immuni.2015.12.005

Vacchini, A., Chancellor, A., Spagnuolo, J., Mori, L. & De Libero, G. MR1-restricted T cells are unprecedented cancer fighters. Front. Immunol. 11, 751 (2020).

pubmed: 32411144 pmcid: 7198878 doi: 10.3389/fimmu.2020.00751

Crowther, M. D. et al. Genome-wide CRISPR–Cas9 screening reveals ubiquitous T cell cancer targeting via the monomorphic MHC class I-related protein MR1. Nat. Immunol. 21, 178–185 (2020). This study finds an MR1T cell clone that appears to recognize cancer antigens presented by MR1.

pubmed: 31959982 pmcid: 6983325 doi: 10.1038/s41590-019-0578-8

Lepore, M. et al. Functionally diverse human T cells recognize non-microbial antigens presented by MR1. eLife 6, e24476 (2017). This study provides evidence of distinct types of MR1-presented cancer antigens recognized by MR1T cells.

pubmed: 28518056 pmcid: 5459576 doi: 10.7554/eLife.24476

Seneviratna, R. et al. Differential antigenic requirements by diverse MR1-restricted T cells. Immunol. Cell Biol. 100, 112–126 (2022).

pubmed: 34940995 pmcid: 9033883 doi: 10.1111/imcb.12519

Blum, J. S., Wearsch, P. A. & Cresswell, P. Pathways of antigen processing. Annu. Rev. Immunol. 31, 443–473 (2013).

pubmed: 23298205 pmcid: 4026165 doi: 10.1146/annurev-immunol-032712-095910

Rock, K. L., Reits, E. & Neefjes, J. Present yourself! By MHC class I and MHC class II molecules. Trends Immunol. 37, 724–737 (2016).

pubmed: 27614798 pmcid: 5159193 doi: 10.1016/j.it.2016.08.010

Villadangos, J. A. & Ploegh, H. L. Proteolysis in MHC class II antigen presentation. Immunity 12, 233–239 (2000).

pubmed: 10755610 doi: 10.1016/S1074-7613(00)80176-4

van de Weijer, M. L., Luteijn, R. D. & Wiertz, E. J. Viral immune evasion: lessons in MHC class I antigen presentation. Semin. Immunol. 27, 125–137 (2015).

pubmed: 25887630 doi: 10.1016/j.smim.2015.03.010

Awad, W. et al. The molecular basis underpinning the potency and specificity of MAIT cell antigens. Nat. Immunol. 21, 400–411 (2020).

pubmed: 32123373 doi: 10.1038/s41590-020-0616-6

Mak, J. Y. et al. Stabilizing short-lived Schiff base derivatives of 5-aminouracils that activate mucosal-associated invariant T cells. Nat. Commun. 8, 14599 (2017).

pubmed: 28272391 pmcid: 5344979 doi: 10.1038/ncomms14599

Tastan, C. et al. Tuning of human MAIT cell activation by commensal bacteria species and MR1-dependent T-cell presentation. Mucosal Immunol. 11, 1591–1605 (2018).

pubmed: 30115998 pmcid: 6279574 doi: 10.1038/s41385-018-0072-x

Mondot, S., Boudinot, P. & Lantz, O. MAIT, MR1, microbes and riboflavin: a paradigm for the co-evolution of invariant TCRs and restricting MHCI-like molecules? Immunogenetics 68, 537–548 (2016).

pubmed: 27393664 doi: 10.1007/s00251-016-0927-9

Schmaler, M. et al. Modulation of bacterial metabolism by the microenvironment controls MAIT cell stimulation. Mucosal Immunol. 11, 1060–1070 (2018).

pubmed: 29743612 doi: 10.1038/s41385-018-0020-9

Georgel, P., Radosavljevic, M., Macquin, C. & Bahram, S. The non-conventional MHC class I MR1 molecule controls infection by Klebsiella pneumoniae in mice. Mol. Immunol. 48, 769–775 (2011).

pubmed: 21190736 doi: 10.1016/j.molimm.2010.12.002

Howson, L. J. et al. Absence of mucosal-associated invariant T cells in a person with a homozygous point mutation in MR1. Sci. Immunol. 5, eabc9492 (2020). This study examines a patient lacking MAIT cells who had a homozygous mutation in MR1 preventing presentation of VitBAg.

pubmed: 32709702 pmcid: 8581949 doi: 10.1126/sciimmunol.abc9492

Klebanoff, C. A., Rosenberg, S. A. & Restifo, N. P. Prospects for gene-engineered T cell immunotherapy for solid cancers. Nat. Med. 22, 26–36 (2016).

pubmed: 26735408 pmcid: 6295670 doi: 10.1038/nm.4015

McWilliam, H. E., Birkinshaw, R. W., Villadangos, J. A., McCluskey, J. & Rossjohn, J. MR1 presentation of vitamin B-based metabolite ligands. Curr. Opin. Immunol. 34, 28–34 (2015).

pubmed: 25603223 doi: 10.1016/j.coi.2014.12.004

Jin, H. et al. Deaza-modification of MR1 ligands modulates recognition by MR1-restricted T cells. Sci. Rep. 12, 22539 (2022).

pubmed: 36581641 pmcid: 9800373 doi: 10.1038/s41598-022-26259-y

Corbett, A. J., Awad, W., Wang, H. & Chen, Z. Antigen recognition by MR1-reactive T cells; MAIT cells, metabolites, and remaining mysteries. Front. Immunol. 11, 1961 (2020).

pubmed: 32973800 pmcid: 7482426 doi: 10.3389/fimmu.2020.01961

Eckle, S. B. et al. A molecular basis underpinning the T cell receptor heterogeneity of mucosal-associated invariant T cells. J. Exp. Med. 211, 1585–1600 (2014).

pubmed: 25049336 pmcid: 4113946 doi: 10.1084/jem.20140484

Keller, A. N. et al. Drugs and drug-like molecules can modulate the function of mucosal-associated invariant T cells. Nat. Immunol. 18, 402–411 (2017). This study reveals that MR1 can present a diverse range of metabolites and drug-like molecules with functional consequences for MAIT cells.

pubmed: 28166217 doi: 10.1038/ni.3679

Naidoo, K. et al. MR1‐dependent immune surveillance of the skin contributes to pathogenesis and is a photobiological target of UV light therapy in a mouse model of atopic dermatitis. Allergy 76, 3155–3170 (2021).

pubmed: 34185885 doi: 10.1111/all.14994

Harriff, M. J. et al. MR1 displays the microbial metabolome driving selective MR1-restricted T cell receptor usage. Sci. Immunol. 3, eaao2556 (2018).

pubmed: 30006464 pmcid: 7085347 doi: 10.1126/sciimmunol.aao2556

Meermeier, E. W. et al. Human TRAV1-2-negative MR1-restricted T cells detect S. pyogenes and alternatives to MAIT riboflavin-based antigens. Nat. Commun. 7, 12506 (2016).

pubmed: 27527800 pmcid: 4990709 doi: 10.1038/ncomms12506

Souter, M. N. T. et al. CD8 coreceptor engagement of MR1 enhances antigen responsiveness by human MAIT and other MR1-reactive T cells. J. Exp. Med. 219, e20210828 (2022).

pubmed: 36018322 pmcid: 9424912 doi: 10.1084/jem.20210828

Ler, G. J. M. et al. Computer modelling and synthesis of deoxy and monohydroxy analogues of a ribitylaminouracil bacterial metabolite that potently activates human T cells. Chemistry 25, 15594–15608 (2019).

pubmed: 31529537 doi: 10.1002/chem.201903732

Mak, J. Y. W., Liu, L. & Fairlie, D. P. Chemical modulators of mucosal associated invariant T cells. Acc. Chem. Res. 54, 3462–3475 (2021).

pubmed: 34415738 pmcid: 8989627 doi: 10.1021/acs.accounts.1c00359

Lange, J. et al. The chemical synthesis, stability, and activity of MAIT cell prodrug agonists that access MR1 in recycling endosomes. ACS Chem. Biol. 15, 437–445 (2020).

pubmed: 31909966 doi: 10.1021/acschembio.9b00902

Harriff, M. J. et al. Human lung epithelial cells contain Mycobacterium tuberculosis in a late endosomal vacuole and are efficiently recognized by CD8

pubmed: 24828674 pmcid: 4020835 doi: 10.1371/journal.pone.0097515

Chen, Z. et al. Mucosal-associated invariant T-cell activation and accumulation after in vivo infection depends on microbial riboflavin synthesis and co-stimulatory signals. Mucosal Immunol. 10, 58–68 (2017).

pubmed: 27143301 doi: 10.1038/mi.2016.39

Lim, H. J. et al. A specialized tyrosine-based endocytosis signal in MR1 controls antigen presentation to MAIT cells. J. Cell Biol. 221, e202110125 (2022). This study reveals the molecular mechanism of MR1 cell surface display and endocytosis.

pubmed: 36129434 pmcid: 9499830 doi: 10.1083/jcb.202110125

Yao, T. et al. MAIT cells accumulate in ovarian cancer-elicited ascites where they retain their capacity to respond to MR1 ligands and cytokine cues. Cancer Immunol. Immunother. 71, 1259–1273 (2021).

pubmed: 34854949 doi: 10.1007/s00262-021-03118-9

Harriff, M. J. et al. Endosomal mr1 trafficking plays a key role in presentation of Mycobacterium tuberculosis ligands to MAIT cells. PLoS Pathog. 12, e1005524 (2016). This study finds several secretory pathway regulators that are required for MR1 antigen presentation.

pubmed: 27031111 pmcid: 4816560 doi: 10.1371/journal.ppat.1005524

Le Nours, J. et al. A class of γδ T cell receptors recognize the underside of the antigen-presenting molecule MR1. Science 366, 1522–1527 (2019).

pubmed: 31857486 doi: 10.1126/science.aav3900

Wilson, N. S., El-Sukkari, D. & Villadangos, J. A. Dendritic cells constitutively present self antigens in their immature state in vivo and regulate antigen presentation by controlling the rates of MHC class II synthesis and endocytosis. Blood 103, 2187–2195 (2004).

pubmed: 14604956 doi: 10.1182/blood-2003-08-2729

Salio, M. et al. Ligand-dependent downregulation of MR1 cell surface expression. Proc. Natl Acad. Sci. USA 117, 10465–10475 (2020).

pubmed: 32341160 pmcid: 7229755 doi: 10.1073/pnas.2003136117

Villadangos, J. A., Schnorrer, P. & Wilson, N. S. Control of MHC class II antigen presentation in dendritic cells: a balance between creative and destructive forces. Immunol. Rev. 207, 191–205 (2005).

pubmed: 16181337 doi: 10.1111/j.0105-2896.2005.00317.x

Huang, S. et al. MR1 uses an endocytic pathway to activate mucosal-associated invariant T cells. J. Exp. Med. 205, 1201–1211 (2008).

pubmed: 18443227 pmcid: 2373850 doi: 10.1084/jem.20072579

McWilliam, H. E. G. et al. Endoplasmic reticulum chaperones stabilize ligand-receptive MR1 molecules for efficient presentation of metabolite antigens. Proc. Natl Acad. Sci. USA 117, 24974–24985 (2020). This study describes a tagged MR1 ligand and uses it to show that MR1 binds extracellular ligands directly in the ER and is stabilized in this compartment by tapasin or TAPBPR.

pubmed: 32958637 pmcid: 7547156 doi: 10.1073/pnas.2011260117

Abós, B. et al. Human MR1 expression on the cell surface is acid sensitive, proteasome independent and increases after culturing at 26 °C. Biochem. Biophys. Res. Commun. 411, 632–636 (2011).

pubmed: 21777569 doi: 10.1016/j.bbrc.2011.07.007

Yamaguchi, H. & Hashimoto, K. Association of MR1 protein, an MHC class I-related molecule, with β

pubmed: 11785959 doi: 10.1006/bbrc.2001.6277

Miley, M. J. et al. Biochemical features of the MHC-related protein 1 consistent with an immunological function. J. Immunol. 170, 6090–6098 (2003).

pubmed: 12794138 doi: 10.4049/jimmunol.170.12.6090

Ljunggren, H. G. et al. Empty MHC class I molecules come out in the cold. Nature 346, 476–480 (1990).

pubmed: 2198471 doi: 10.1038/346476a0

Nelson, C. A., Petzold, S. J. & Unanue, E. R. Peptides determine the lifespan of MHC class II molecules in the antigen-presenting cell. Nature 371, 250–252 (1994).

pubmed: 8078585 doi: 10.1038/371250a0

Sadegh-Nasseri, S., Stern, L. J., Wiley, D. C. & Germain, R. N. MHC class II function preserved by low-affinity peptide interactions preceding stable binding. Nature 370, 647–650 (1994).

pubmed: 8065450 doi: 10.1038/370647a0

Hill, A. et al. Herpes simplex virus turns off the TAP to evade host immunity. Nature 375, 411–415 (1995).

pubmed: 7760935 doi: 10.1038/375411a0

Kulicke, C. A. et al. The P5-type ATPase ATP13A1 modulates major histocompatibility complex I-related protein 1 (MR1)-mediated antigen presentation. J. Biol. Chem. 298, 101542 (2021). This study uses a genome-wide screen to reveal that MR1 levels and antigen presentation are modulated by the loss of the P5-type ATPase ATP13A1.

pubmed: 34968463 pmcid: 8808182 doi: 10.1016/j.jbc.2021.101542

McKenna, M. J. et al. The endoplasmic reticulum P5A-ATPase is a transmembrane helix dislocase. Science 369, eabc5809 (2020).

pubmed: 32973005 pmcid: 8053355 doi: 10.1126/science.abc5809

Blees, A. et al. Structure of the human MHC-I peptide-loading complex. Nature 551, 525–528 (2017).

pubmed: 29107940 doi: 10.1038/nature24627

Wearsch, P. A. & Cresswell, P. Selective loading of high-affinity peptides onto major histocompatibility complex class I molecules by the tapasin–ERp57 heterodimer. Nat. Immunol. 8, 873–881 (2007).

pubmed: 17603487 doi: 10.1038/ni1485

Jiang, J. et al. Crystal structure of a TAPBPR–MHC-I complex reveals the mechanism of peptide editing in antigen presentation. Science 358, 1064–1068 (2017).

pubmed: 29025991 pmcid: 6320693 doi: 10.1126/science.aao5154

Boyle, L. H. et al. Tapasin-related protein TAPBPR is an additional component of the MHC class I presentation pathway. Proc. Natl Acad. Sci. USA 110, 3465–3470 (2013).

pubmed: 23401559 pmcid: 3587277 doi: 10.1073/pnas.1222342110

Neerincx, A. & Boyle, L. H. Properties of the tapasin homologue TAPBPR. Curr. Opin. Immunol. 46, 97–102 (2017).

pubmed: 28528220 doi: 10.1016/j.coi.2017.04.008

Thomas, C. & Tampe, R. Proofreading of peptide–MHC complexes through dynamic multivalent interactions. Front. Immunol. 8, 65 (2017).

pubmed: 28228754 pmcid: 5296336 doi: 10.3389/fimmu.2017.00065

Dong, G., Wearsch, P. A., Peaper, D. R., Cresswell, P. & Reinisch, K. M. Insights into MHC class I peptide loading from the structure of the tapasin–ERp57 thiol oxidoreductase heterodimer. Immunity 30, 21–32 (2009).

pubmed: 19119025 pmcid: 2650231 doi: 10.1016/j.immuni.2008.10.018

Thomas, C. & Tampe, R. MHC I assembly and peptide editing—chaperones, clients, and molecular plasticity in immunity. Curr. Opin. Immunol. 70, 48–56 (2021).

pubmed: 33689959 doi: 10.1016/j.coi.2021.02.004

Purcell, A. W. et al. Quantitative and qualitative influences of tapasin on the class I peptide repertoire. J. Immunol. 166, 1016–1027 (2001).

pubmed: 11145681 doi: 10.4049/jimmunol.166.2.1016

McShan, A. C. et al. TAPBPR employs a ligand-independent docking mechanism to chaperone MR1 molecules. Nat. Chem. Biol. 18, 859–868 (2022). This study provides the structural basis for how TAPBPR chaperones MR1.

pubmed: 35725941 pmcid: 9703140 doi: 10.1038/s41589-022-01049-9

Bashirova, A. A. et al. HLA tapasin independence: broader peptide repertoire and HIV control. Proc. Natl Acad. Sci. USA 117, 28232–28238 (2020).

pubmed: 33097667 pmcid: 7668082 doi: 10.1073/pnas.2013554117

Peh, C. A., Laham, N., Burrows, S. R., Zhu, Y. & McCluskey, J. Distinct functions of tapasin revealed by polymorphism in MHC class I peptide loading. J. Immunol. 164, 292–299 (2000).

pubmed: 10605023 doi: 10.4049/jimmunol.164.1.292

Ussher, J. E. et al. TLR signalling in human antigen-presenting cells regulates MR1-dependent activation of MAIT cells. Eur. J. Immunol. 46, 1600–1614 (2016).

pubmed: 27105778 pmcid: 5297987 doi: 10.1002/eji.201545969

Liu, J. & Brutkiewicz, R. R. The Toll-like receptor 9 signalling pathway regulates MR1-mediated bacterial antigen presentation in B cells. Immunol 152, 232–242 (2017).

doi: 10.1111/imm.12759

Villadangos, J. A. et al. MHC class II expression is regulated in dendritic cells independently of invariant chain degradation. Immunity 14, 739–749 (2001).

pubmed: 11420044 doi: 10.1016/S1074-7613(01)00148-0

Vembar, S. S. & Brodsky, J. L. One step at a time: endoplasmic reticulum-associated degradation. Nat. Rev. Mol. Cell Biol. 9, 944–957 (2008).

pubmed: 19002207 pmcid: 2654601 doi: 10.1038/nrm2546

Purohit, S. K. et al. Varicella zoster virus impairs expression of the non-classical major histocompatibility complex class I-related gene protein (MR1). J. Infect. Dis. 227, 391–401 (2021).

pmcid: 9891426 doi: 10.1093/infdis/jiab526

McSharry, B. P. et al. Virus-mediated suppression of the antigen presentation molecule MR1. Cell Rep. 30, 2948–2962.e4 (2020). This study is the first to reveal that viruses can specifically target MR1 for degradation.

pubmed: 32130899 pmcid: 7798347 doi: 10.1016/j.celrep.2020.02.017

Ashley, C. L. et al. Suppression of MR1 by human cytomegalovirus inhibits MAIT cell activation. Front Immunol. 14, 1107497 (2023).

pubmed: 36845106 pmcid: 9950634 doi: 10.3389/fimmu.2023.1107497

Samer, C. et al. Viral impacts on MR1 antigen presentation to MAIT cells. Crit. Rev. Immunol. 41, 49–67 (2021).

pubmed: 35381139 doi: 10.1615/CritRevImmunol.2022041981

Nikolich-Zugich, J., Slifka, M. K. & Messaoudi, I. The many important facets of T-cell repertoire diversity. Nat. Rev. Immunol. 4, 123–132 (2004).

pubmed: 15040585 doi: 10.1038/nri1292

Corse, E., Gottschalk, R. A. & Allison, J. P. Strength of TCR–peptide/MHC interactions and in vivo T cell responses. J. Immunol. 186, 5039–5045 (2011).

pubmed: 21505216 doi: 10.4049/jimmunol.1003650

Adams, B. M., Oster, M. E. & Hebert, D. N. Protein quality control in the endoplasmic reticulum. Protein J. 38, 317–329 (2019).

pubmed: 31004255 pmcid: 6589386 doi: 10.1007/s10930-019-09831-w

Caramelo, J. J., Castro, O. A., Alonso, L. G., De Prat-Gay, G. & Parodi, A. J. UDP-Glc:glycoprotein glucosyltransferase recognizes structured and solvent accessible hydrophobic patches in molten globule-like folding intermediates. Proc. Natl Acad. Sci. USA 100, 86–91 (2003).

pubmed: 12518055 doi: 10.1073/pnas.262661199

Vassilakos, A., Cohen-Doyle, M. F., Peterson, P. A., Jackson, M. R. & Williams, D. B. The molecular chaperone calnexin facilitates folding and assembly of class I histocompatibility molecules. EMBO J. 15, 1495–1506 (1996).

pubmed: 8612572 pmcid: 450057 doi: 10.1002/j.1460-2075.1996.tb00493.x

Peaper, D. R. & Cresswell, P. Regulation of MHC class I assembly and peptide binding. Annu. Rev. Cell Dev. Biol. 24, 343–368 (2008).

pubmed: 18729726 doi: 10.1146/annurev.cellbio.24.110707.175347

McWilliam, H. E. G. & Villadangos, J. A. How MR1 presents a pathogen metabolic signature to mucosal-associated invariant T (MAIT) cells. Trends Immunol. 38, 679–689 (2017).

pubmed: 28688841 doi: 10.1016/j.it.2017.06.005

Kumari, S., Mg, S. & Mayor, S. Endocytosis unplugged: multiple ways to enter the cell. Cell Res. 20, 256–275 (2010).

pubmed: 20125123 doi: 10.1038/cr.2010.19

Doherty, G. J. & McMahon, H. T. Mechanisms of endocytosis. Annu. Rev. Biochem. 78, 857–902 (2009).

pubmed: 19317650 doi: 10.1146/annurev.biochem.78.081307.110540

Ohno, H. et al. The medium subunits of adaptor complexes recognize distinct but overlapping sets of tyrosine-based sorting signals. J. Biol. Chem. 273, 25915–25921 (1998).

pubmed: 9748267 doi: 10.1074/jbc.273.40.25915

Karamooz, E., Harriff, M. J., Narayanan, G. A., Worley, A. & Lewinsohn, D. M. MR1 recycling and blockade of endosomal trafficking reveal distinguishable antigen presentation pathways between Mycobacterium tuberculosis infection and exogenously delivered antigens. Sci. Rep. 9, 4797 (2019).

pubmed: 30886396 pmcid: 6423294 doi: 10.1038/s41598-019-41402-y

McWilliam, H. E. & Villadangos, J. A. MR1 antigen presentation to MAIT cells: new ligands, diverse pathways? Curr. Opin. Immunol. 52, 108–113 (2018).

pubmed: 29754112 doi: 10.1016/j.coi.2018.04.022

Karamooz, E., Harriff, M. J. & Lewinsohn, D. M. MR1-dependent antigen presentation. Semin. Cell Dev. Biol. 84, 58–64 (2018).

pubmed: 30449535 pmcid: 7061520 doi: 10.1016/j.semcdb.2017.11.028

Kulicke, C., Karamooz, E., Lewinsohn, D. & Harriff, M. Covering all the bases: complementary MR1 antigen presentation pathways sample diverse antigens and intracellular compartments. Front. Immunol. 11, 2034 (2020).

pubmed: 32983150 pmcid: 7492589 doi: 10.3389/fimmu.2020.02034

McWilliam, H. E. & Villadangos, J. A. MR1: a multi-faceted metabolite sensor for T cell activation. Curr. Opin. Immunol. 64, 124–129 (2020).

pubmed: 32604057 doi: 10.1016/j.coi.2020.05.006

Eggensperger, S. & Tampe, R. The transporter associated with antigen processing: a key player in adaptive immunity. Biol. Chem. 396, 1059–1072 (2015).

pubmed: 25781678 doi: 10.1515/hsz-2014-0320

Sandvig, K. & Van Deurs, B. Transport of protein toxins into cells: pathways used by ricin, cholera toxin and Shiga toxin. FEBS Lett. 529, 49–53 (2002).

pubmed: 12354612 doi: 10.1016/S0014-5793(02)03182-4

Ackerman, A. L., Kyritsis, C., Tampe, R. & Cresswell, P. Access of soluble antigens to the endoplasmic reticulum can explain cross-presentation by dendritic cells. Nat. Immunol. 6, 107–113 (2005).

pubmed: 15592474 doi: 10.1038/ni1147

Zhang, Y. et al. Mucosal-associated invariant T cells restrict reactive oxidative damage and preserve meningeal barrier integrity and cognitive function. Nat. Immunol. 23, 1714–1725 (2022).

pubmed: 36411380 doi: 10.1038/s41590-022-01349-1

Soudais, C. et al. In vitro and in vivo analysis of the Gram-negative bacteria-derived riboflavin precursor derivatives activating mouse MAIT cells. J. Immunol. 194, 4641–4649 (2015).

pubmed: 25870247 doi: 10.4049/jimmunol.1403224

Patel, O. et al. Recognition of vitamin B metabolites by mucosal-associated invariant T cells. Nat. Commun. 4, 2142 (2013).

pubmed: 23846752 doi: 10.1038/ncomms3142

Pentcheva, T., Spiliotis, E. T. & Edidin, M. Cutting edge: tapasin is retained in the endoplasmic reticulum by dynamic clustering and exclusion from endoplasmic reticulum exit sites. J. Immunol. 168, 1538–1541 (2002).

pubmed: 11823478 doi: 10.4049/jimmunol.168.4.1538

Barnden, M. J., Purcell, A. W., Gorman, J. J. & McCluskey, J. Tapasin-mediated retention and optimization of peptide ligands during the assembly of class I molecules. J. Immunol. 165, 322–330 (2000).

pubmed: 10861068 doi: 10.4049/jimmunol.165.1.322

Meyerholz, A. et al. Effect of clathrin assembly lymphoid myeloid leukemia protein depletion on clathrin coat formation. Traffic 6, 1225–1234 (2005).

pubmed: 16262731 doi: 10.1111/j.1600-0854.2005.00355.x

Kaksonen, M. & Roux, A. Mechanisms of clathrin-mediated endocytosis. Nat. Rev. Mol. Cell Biol. 19, 313–326 (2018).

pubmed: 29410531 doi: 10.1038/nrm.2017.132

Traub, L. M. & Bonifacino, J. S. Cargo recognition in clathrin-mediated endocytosis. Cold Spring Harb. Perspect. Biol. 5, a016790 (2013).

pubmed: 24186068 pmcid: 3809577 doi: 10.1101/cshperspect.a016790

Dickson, L. J., Liu, S. & Storrie, B. Rab6 is required for rapid, cisternal-specific, intra-Golgi cargo transport. Sci. Rep. 10, 16604 (2020).

pubmed: 33024151 pmcid: 7538953 doi: 10.1038/s41598-020-73276-w

Martinez, O. et al. The small GTP-binding protein rab6 functions in intra-Golgi transport. J. Cell Biol. 127, 1575–1588 (1994).

pubmed: 7798313 doi: 10.1083/jcb.127.6.1575

Martinez, O. et al. GTP-bound forms of rab6 induce the redistribution of Golgi proteins into the endoplasmic reticulum. Proc. Natl Acad. Sci. USA 94, 1828–1833 (1997).

pubmed: 9050864 pmcid: 20002 doi: 10.1073/pnas.94.5.1828

Utskarpen, A., Slagsvold, H. H., Iversen, T.-G., Wälchli, S. & Sandvig, K. Transport of ricin from endosomes to the Golgi apparatus is regulated by Rab6A and Rab6A′. Traffic 7, 663–672 (2006).

pubmed: 16683916 doi: 10.1111/j.1600-0854.2006.00418.x

Mallard, F. et al. Early/recycling endosomes-to-TGN transport involves two SNARE complexes and a Rab6 isoform. J. Cell Biol. 156, 653–664 (2002).

pubmed: 11839770 pmcid: 2174079 doi: 10.1083/jcb.200110081

Spessott, W. A., Sanmillan, M. L., Kulkarni, V. V., McCormick, M. E. & Giraudo, C. G. Syntaxin 4 mediates endosome recycling for lytic granule exocytosis in cytotoxic T-lymphocytes. Traffic 18, 442–452 (2017).

pubmed: 28471021 pmcid: 5513838 doi: 10.1111/tra.12490

Stow, J. L., Manderson, A. P. & Murray, R. Z. SNAREing immunity: the role of SNAREs in the immune system. Nat. Rev. Immunol. 6, 919–929 (2006).

pubmed: 17124513 doi: 10.1038/nri1980

Ganley, I. G., Espinosa, E. & Pfeffer, S. R. A syntaxin 10–SNARE complex distinguishes two distinct transport routes from endosomes to the trans-Golgi in human cells. J. Cell Biol. 180, 159–172 (2008).

pubmed: 18195106 pmcid: 2213607 doi: 10.1083/jcb.200707136

Hirose, H. et al. Implication of ZW10 in membrane trafficking between the endoplasmic reticulum and Golgi. EMBO J. 23, 1267–1278 (2004).

pubmed: 15029241 pmcid: 381410 doi: 10.1038/sj.emboj.7600135

Hatsuzawa, K. et al. Syntaxin 18, a SNAP receptor that functions in the endoplasmic reticulum, intermediate compartment, and cis-Golgi vesicle trafficking. J. Biol. Chem. 275, 13713–13720 (2000).

pubmed: 10788491 doi: 10.1074/jbc.275.18.13713

Williams, D. & Pessin, J. E. Mapping of R-SNARE function at distinct intracellular GLUT4 trafficking steps in adipocytes. J. Cell Biol. 180, 375–387 (2008).

pubmed: 18227281 pmcid: 2213575 doi: 10.1083/jcb.200709108

Fritzius, T., Frey, A. D., Schweneker, M., Mayer, D. & Moelling, K. WD-repeat-propeller-FYVE protein, ProF, binds VAMP2 and protein kinase Cζ. FEBS J. 274, 1552–1566 (2007).

pubmed: 17313651 doi: 10.1111/j.1742-4658.2007.05702.x

Shitara, A. et al. VAMP4 is required to maintain the ribbon structure of the Golgi apparatus. Mol. Cell. Biochem. 380, 11–21 (2013).

pubmed: 23677696 pmcid: 3695666 doi: 10.1007/s11010-013-1652-4

Imai, T. et al. Us3 kinase encoded by herpes simplex virus 1 mediates downregulation of cell surface major histocompatibility complex class I and evasion of CD8

pubmed: 23951282 pmcid: 3741198 doi: 10.1371/journal.pone.0072050

Rao, P. et al. Herpes simplex virus 1 glycoprotein B and US3 collaborate to inhibit CD1d antigen presentation and NKT cell function. J. Virol. 85, 8093–8104 (2011).

pubmed: 21653669 pmcid: 3147970 doi: 10.1128/JVI.02689-10

Seidel, E. et al. Dynamic co-evolution of host and pathogen: HCMV downregulates the prevalent allele MICA*008 to escape elimination by NK cells. Cell Rep. 10, 968–982 (2015).

pubmed: 25683719 pmcid: 4641326 doi: 10.1016/j.celrep.2015.01.029

Abendroth, A., Lin, I., Slobedman, B., Ploegh, H. & Arvin, A. M. Varicella-zoster virus retains major histocompatibility complex class I proteins in the Golgi compartment of infected cells. J. Virol. 75, 4878–4888 (2001).

pubmed: 11312359 pmcid: 114242 doi: 10.1128/JVI.75.10.4878-4888.2001

Riegert, P., Wanner, V. & Bahram, S. Genomics, isoforms, expression, and phylogeny of the MHC class I-related MR1 gene. J. Immunol. 161, 4066–4077 (1998).

pubmed: 9780177 doi: 10.4049/jimmunol.161.8.4066

Yamaguchi, H., Hirai, M., Kurosawa, Y. & Hashimoto, K. A highly conserved major histocompatibility complex class I-related gene in mammals. Biochem. Biophys. Res. Commun. 238, 697–702 (1997).

pubmed: 9325151 doi: 10.1006/bbrc.1997.7379

Tsukamoto, K., Deakin, J. E., Graves, J. A. & Hashimoto, K. Exceptionally high conservation of the MHC class I-related gene, MR1, among mammals. Immunogenetics 65, 115–124 (2013).

pubmed: 23229473 doi: 10.1007/s00251-012-0666-5

Robinson, J. et al. IPD-IMGT/HLA database. Nucleic Acids Res. 48, D948–D955 (2020).

pubmed: 31667505

Sarkizova, S. et al. A large peptidome dataset improves HLA class I epitope prediction across most of the human population. Nat. Biotechnol. 38, 199–209 (2020).

pubmed: 31844290 doi: 10.1038/s41587-019-0322-9

Rozemuller, E. et al. MR1 encompasses at least six allele groups with coding region alterations. HLA 98, 509–516 (2021).

pubmed: 34351076 doi: 10.1111/tan.14390

Seshadri, C. et al. A polymorphism in human MR1 is associated with mRNA expression and susceptibility to tuberculosis. Genes. Immun. 18, 8–14 (2017).

pubmed: 27881839 doi: 10.1038/gene.2016.41

Robinson, J. et al. Distinguishing functional polymorphism from random variation in the sequences of >10,000 HLA-A, -B and -C alleles. PLOS Genet. 13, e1006862 (2017).

pubmed: 28650991 pmcid: 5507469 doi: 10.1371/journal.pgen.1006862

Huang, S. et al. MR1 antigen presentation to mucosal-associated invariant T cells was highly conserved in evolution. Proc. Natl Acad. Sci. USA 106, 8290–8295 (2009).

pubmed: 19416870 pmcid: 2688861 doi: 10.1073/pnas.0903196106

Boudinot, P. et al. Restricting nonclassical MHC genes coevolve with TRAV genes used by innate-like T cells in mammals. Proc. Natl Acad. Sci. USA 113, E2983–E2992 (2016). This study describes MR1 conservation in mammalian evolution and finds that MR1 and the MAIT cell TCRα chain (TRAV1) are intricately intertwined through evolution.

pubmed: 27170188 pmcid: 4889381 doi: 10.1073/pnas.1600674113

MR1 antigen presentation to MAIT cells and other MR1-restricted T cells.

Journal

Informations de publication

Résumé

Identifiants

Types de publication

Langues

Sous-ensembles de citation

Informations de copyright

Références

Auteurs

Hamish E G McWilliam (HEG)

Jose A Villadangos (JA)

Classifications MeSH